MARIZYME, INC. — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$645.8K

Net Income/Loss (FY2023)

-$69.5M

Total Assets (FY2023)

$22.0M

Total Equity (FY2023)

-$6.7M

Cash Flows from Operating Activities (FY2023)

-$4.7M

Source: MARIZYME, INC. 10-K/A filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.